H3 Biomedicine and Selvita Extend Precision Cancer Medicines Collaboration

Cambridge, MA and Krakow, Poland, September 22, 2015 — H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of precision oncology treatments, and Selvita (PL: SLV), the largest drug discovery company in Central and Eastern Europe, announced today that they have extended their strategic collaboration to develop…

More

Polish Prime Minister visits Selvita

Krakow, 22 October 2015 – Polish Prime Minister, Ewa Kopacz, currently touring the country on a pre-election tour, visited today Krakow, paying a visit to the Life Science Park where Selvita laboratories are located.    Mrs Kopacz was joined by Mrs Roza Thun, Member of the European Parliament for Poland,…

More

Selvita shows dynamic revenue growth in H1 2015

Kraków, 13 August 2015 – The first half-year of 2015 is the third consecutive six-month period in which the Selvita Group achieved an operating profit. This positive result is the effect of the continued profitable operations in both innovations and services.   In H1 2015 the Selvita Group recorded a…

More

Selvita initiates IND-enabling Studies for its first-in-class PIM/FLT3 inhibitor

Krakow, 31 March 2015 – Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, announced today that it is commencing IND-enabling studies for SEL24 project, the company’s first oncology drug candidate.   SEL24 is a novel, orally-available small molecule, selective inhibitor of PIM and FLT3 kinases, with…

More

Selvita establishes its UK subsidiary in Cambridge

Cambridge, UK – Krakow, Poland – 05 May 2015 – Selvita (WSE: SLV), a global drug discovery company with offices in the US and Poland, is opening its first office in the United Kingdom. The office is based in Cambridge, considered to be one of the most significant biotechnology clusters…

More

Selvita receives the Economic Award of the President of Poland

Krakow, 07 May 2015 – Selvita, a global drug discovery company engaged in the development of breakthrough oncology treatments and drug discovery services, was awarded the Economic Award of the President of Poland in the category Innovation.   The award was presented by the President of Poland, Mr. Bronislaw Komorowski…

More

...89101112...